The virus-like particle technology is the most competitive and critical platform in Zerun Biotech. The platform technology has taken the domestic lead in the aspects of VLP purification, reassembly and disassembly, and the stability of formulation. In the aspects of advanced structure analysis and particle uniformity, Zerun Biotech has reached the international advanced standards.

 Zerun Biotech has established a competitive Recombinant Protein Expression Technology Platform, including E. coli, Baculovirus-insect cell, yeast and mammalian CHO cell expression systems, to express various antigens based on the characteristics of target proteins. Moreover, we further genetically engineered each system to make it have more advantages for industrial use.

Innovative adjuvant evaluation platform is led by domestic and foreign technical talents. With advanced instruments including Analytic Ultra-centrifuge, Dynamic Lighting Scattering, Differential Scanning Calorimetry, Mass Spectrometer and Flow Cytometer, Zerun Biotech has established an evaluation system for physical-chemical properties, stability and immunogenicity enhancement of various adjuvants. Novel adjuvant has been developed into clinical trials.

To further expand the research and development technical platform of vaccine, Zerun Biotech has developed mRNA vaccine technical platform through independent research and external cooperation, and has built a professional research team.